Status:
COMPLETED
Comparison of Voice Results at 5 Years of Treatment of Glottic Squamous Cell Carcinoma T1 by Surgery Versus Radiotherapy
Lead Sponsor:
University Hospital, Lille
Conditions:
Glottic Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
Patients with early-stage squamous cell carcinomas of the vocal cord can be treated in an equivalent way in terms of carcinology by surgery or radiotherapy. The study will be to analyse the vocal outc...
Eligibility Criteria
Inclusion
- Patients with glottic squamous cell carcinoma T1N0M0 who may benefit from treatment with exclusive radiotherapy or exclusive surgery.
- patients treated for these cancers at Lille University Hospital and the Oscar Lambret Centre between 2015 and 2017.
- Tis, T1a and T1b glottic squamous cell carcinomas according to the TNM 7th edition classification in long-term survivors.
Exclusion
- \-
Key Trial Info
Start Date :
November 3 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 19 2022
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT04447456
Start Date
November 3 2020
End Date
January 19 2022
Last Update
February 6 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Oscar Lambret
Lille, France, 59000
2
Hôpital Huriez, CHU
Lille, France